Literature DB >> 18679168

Immune mediators in idiopathic nephrotic syndrome: evidence for a relation between interleukin 8 and proteinuria.

Marcelo F O Souto1, Antônio L Teixeira, Remo C Russo, Maria-Goretti M G Penido, Kátia D Silveira, Mauro M Teixeira, Ana C Simões E Silva.   

Abstract

The pathogenesis of idiopathic nephrotic syndrome (INS) remains unknown. Several findings suggest a role for the immune system. This study aimed to evaluate immune mediators in INS by measuring plasma and urinary levels of transforming growth factor beta1 (TGF-beta1), monocyte chemoattractant protein-1 (MCP-1/CCL2), regulated on activation normal T-cell expressed and secreted (RANTES/CCL5) and IL-8 (IL-8/CXCL8) in pediatric patients with INS and in age-matched healthy controls. Patients were divided according to their response to corticosteroids: steroid-sensitive (SS, n = 8), or steroid-resistant (SR, n = 24). Immune mediators were also compared in regard with disease activity (relapse and remission). Immune mediators were measured by ELISA. Plasma TGF-beta1 levels in SR patients were approximately 2.8-fold higher than control values (p < 0.05). Urinary IL-8/CXCL8 was 2.9-fold higher in INS patients in relapse (proteinuria >100 mg/m2/24 h) when compared with patients in remission (p < 0.05), and levels had a positive correlation with individual proteinuria values (p < 0.05). Urinary IL-8/CXCL8 was significantly higher in relapsed SR than in SS patients in remission. No changes in MCP-1/CCL2 and RANTES/CCL5 levels were detected. Our findings suggest that IL-8/CXCL8 and TGF-beta1 are involved in the pathogenesis of INS: IL-8/CXCL8 associated with local changes in glomerular permeability and TGF-beta1 could be related to worse response to corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679168     DOI: 10.1203/PDR.0b013e318186ddb2

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  19 in total

Review 1.  The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Fábio Tadeu Lourenço Guimarães; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões e Silva
Journal:  Inflamm Res       Date:  2014-01       Impact factor: 4.575

2.  Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.

Authors:  Heloisa Reniers Vianna; Cristina Maria Bouissou M Soares; Katia Daniela Silveira; Gustavo Siqueira Elmiro; Philipe Melgaço Mendes; Marcelo de Sousa Tavares; Mauro Martins Teixeira; Débora Marques Miranda; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-11-18       Impact factor: 3.714

Review 3.  Childhood nephrotic syndrome--current and future therapies.

Authors:  Larry A Greenbaum; Rainer Benndorf; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

4.  Histone deacetylase-2 expression and activity in children with nephrotic syndrome with different glucocorticoid response.

Authors:  Feng-Jun Guan; Qian-Qian Peng; Lin-Li Wang; Xue-Bo Yan; Chen Dong; Xiao-Hua Jiang
Journal:  Pediatr Nephrol       Date:  2017-11-02       Impact factor: 3.714

5.  Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules.

Authors:  Érica Leandro Marciano Vieira; Natalia Pessoa Rocha; Fernando Macedo Bastos; Kátia Daniela da Silveira; Alamanda K Pereira; Eduardo Araújo Oliveira; Débora Marques de Miranda; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2017-02-22       Impact factor: 3.714

6.  Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study.

Authors:  André Barreto Pereira; Antônio Lúcio Teixeira; Nilton Alves Rezende; Regina Maria Pereira; Débora Marques Miranda; Eduardo Araujo Oliveira; Mauro M Teixeira; Ana Cristina Simões E Silva
Journal:  Int Urol Nephrol       Date:  2012-04-28       Impact factor: 2.370

7.  Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria.

Authors:  Augusto C S Santos; Eleonora M Lima; Maria Goretti M G Penido; Katia D Silveira; Mauro M Teixeira; Eduardo A Oliveira; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-01-07       Impact factor: 3.714

8.  Renal Inflammation in DOCA-Salt Hypertension.

Authors:  Christopher T Banek; Madeline M Gauthier; Dusty A Van Helden; Gregory D Fink; John W Osborn
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

9.  Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies.

Authors:  Mariana A Vasconcelos; Maria Candida F Bouzada; Katia D Silveira; Leticia R Moura; Fabiana F Santos; Juliana M Oliveira; Flavia F Carvalho; Mauro M Teixeira; Ana Cristina Simões E Silva; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2011-02-18       Impact factor: 3.714

10.  Montelukast as an add-on treatment in steroid dependant nephrotic syndrome, randomised-controlled trial.

Authors:  Magdy Mohamed Zedan; Ahmed El-Refaey; Hosam Zaghloul; Mohamed E A Abdelrahim; Amal Osman; Mohamed M Zedan; Nashwa Eltantawy
Journal:  J Nephrol       Date:  2016-03-31       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.